Research & Development
EU Commission decides not to renew AstraZeneca and J&J COVID-19 vaccine contracts next year
14 April 2021 -

Reuters news agency revealed on Wednesday that the European Commission has decided not to renew COVID-19 vaccine contracts next year with companies such as Astrazeneca and Johnson & Johnson (J&J), according to a report from Italian daily La Stampa which cited a source from the Italian Health Ministry.

La Stampa disclosed that in agreement with the leaders of several (EU) countries, the EU Commission has decided that the contracts with the companies that produce (viral vector) vaccines that are valid for the current year will not be renewed on expiry.

Reportedly, Brussels would rather focus on COVID-19 vaccines from companies such as Pfizer and Moderna that use messenger RNA (mRNA) technology.

In addition, Reuters said the EC is seeking clarification from J&J about the company's "completely unexpected" announcement of delays in COVID-19 vaccine deliveries to the EU.

Login
Username:

Password: